| 000 | 01680cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030720.0 | ||
| 008 | 121128s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.19.M.Sc.2012.Do.I | ||
| 100 | 0 | _aDoaa Mahdy Mohamed Mahmoud Elwakil | |
| 245 | 1 | 0 |
_aInducible clindamycin resistance in staphylococcus aureus / _cDoaa Mahdy Mohamed Mahmoud Elwakil ; Supervised Azza Esam Eldin Badr , Nadia Hafez Salah Eldin Auda |
| 246 | 1 | 5 | _aمقاومة الكلينداميسين المستحدثة فى المكورات العنقودية الذهبية |
| 260 |
_aCairo : _bDoaa Mahdy Mohamed Mahmoud Elwakil , _c2012 |
||
| 300 |
_a149 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Microbiology and Immunology | ||
| 520 | _aStaphylococcus aureus is an important cause of nosocomial and community-associated infections in every region of the world. Clindamycin is one of the alternative agents used to treat S. aureus infections and accurate identification of CL resistance is important to prevent therapeutic failure. Unfortunately, inducible CL resistance is not detected by standard susceptibility tests | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aD-zone test | |
| 653 | 4 | _aInducible CL resistance | |
| 653 | 4 | _aS. aureus | |
| 700 | 0 |
_aAzza Esam Eldin Badr , _eSupervisor |
|
| 700 | 0 |
_aNadia Hafez Salah Eldin Auda , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c40417 _d40417 |
||